Update on intravenous lysis treatment : The REVISION trial

CONCLUSION: The efficacy of intravenous thrombolysis in acute ischemic stroke is critically time dependent. This may also be assumed in acute CRAO; however, definite evidence still needs to be provided. Until then, the motto "time is retina" should be applied and intravenous thrombolysis should be offered to CRAO patients as part of randomized trials (such as REVISION). According to the current literature, other acute treatment approaches (such as paracentesis) are not indicated.PMID:34351478 | DOI:10.1007/s00347-021-01467-5
Source: Der Ophthalmologe - Category: Opthalmology Authors: Source Type: research